FIG. 151 Ethmoid bone from behind. FIG. 152 Ethmoid bone from the right side. FIG. 153 Lateral wall of nasal cavity, showing ethmoid bone in position. In front of the lamina papyracea are some broken air cells which are overlapped and completed by the lacrimal bone and the frontal process of the maxilla.IG. 151 Ethmoid bone from behind. FIG. 152 Ethmoid bone from the right side. FIG. 153 Lateral wall of nasal cavity, showing ethmoid bone in position. In front of the lamina papyracea are some broken air cells which are overlapped and completed by the lacrimal bone and the frontal process of the maxilla.
Nusinersen sodium is administered intrathecally.1. 1  Dosing Information1. 2  Available as nusinersen sodium; dosage expressed in terms of nusinersen.1. 3  The recommended dosage is 12 mg (5 mL) per administration. 1.
Psychiatry. Maximum dose of lorazepam for short term, symptomatic treatment is 4 mg per day for severe, disabling anxiety, and 2 mg per day for severe, disabling insomnia. Article date: October 2007. Lorazepam is a benzodiazepine anxiolytic; its indications include short-term use in anxiety or insomnia. The maximum dose of lorazepam is 4 mg per day for the short-term treatment of anxiety and phobia, and is 2 mg per day for the treatment of insomnia.